Veracyte Inc. (NASDAQ:VCYT) went down by -13.53% from its latest closing price compared to the recent 1-year high of $86.03. The company’s stock price has collected -16.69% of loss in the last five trading sessions. Press Release reported on 02/18/21 that Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference
Is It Worth Investing in Veracyte Inc. (NASDAQ :VCYT) Right Now?
Plus, the 36-month beta value for VCYT is at 0.75. Opinions of the stock are interesting as 6 analysts out of 8 who provided ratings for Veracyte Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 1 as “sell.”
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The average price from analysts is $84.83, which is $21.74 above the current price. VCYT currently public float of 57.64M and currently shorts hold a 6.92% ratio of that float. Today, the average trading volume of VCYT was 853.66K shares.
VCYT’s Market Performance
VCYT stocks went down by -16.69% for the week, with a monthly jump of 16.90% and a quarterly performance of 31.44%, while its annual performance rate touched 149.96%. The volatility ratio for the week stands at 9.19% while the volatility levels for the past 30 days are set at 8.96% for Veracyte Inc.. The simple moving average for the period of the last 20 days is -6.96% for VCYT stocks with a simple moving average of 57.31% for the last 200 days.
Analysts’ Opinion of VCYT
Many brokerage firms have already submitted their reports for VCYT stocks, with Needham repeating the rating for VCYT by listing it as a “Buy.” The predicted price for VCYT in the upcoming period, according to Needham is $88 based on the research report published on February 18th of the current year 2021.
Truist, on the other hand, stated in their research note that they expect to see VCYT reach a price target of $61. The rating they have provided for VCYT stocks is “Buy” according to the report published on January 28th, 2021.
KeyBanc Capital Markets gave a rating of “Sector Weight” to VCYT, setting the target price at $48 in the report published on November 10th of the previous year.
VCYT Trading at 7.89% from the 50-Day Moving Average
After a stumble in the market that brought VCYT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.67% of loss for the given period.
Volatility was left at 8.96%, however, over the last 30 days, the volatility rate increased by 9.19%, as shares surge +14.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.57% upper at present.
During the last 5 trading sessions, VCYT fell by -16.69%, which changed the moving average for the period of 200-days by +132.12% in comparison to the 20-day moving average, which settled at $68.20. In addition, Veracyte Inc. saw 28.91% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at VCYT starting from Anderson Bonnie H, who sale 18,541 shares at the price of $51.05 back on Jan 13. After this action, Anderson Bonnie H now owns 203,756 shares of Veracyte Inc., valued at $946,462 using the latest closing price.
Anderson Bonnie H, the Chairman and CEO of Veracyte Inc., sale 20,354 shares at $50.20 during a trade that took place back on Jan 12, which means that Anderson Bonnie H is holding 203,756 shares at $1,021,772 based on the most recent closing price.
Stock Fundamentals for VCYT
Current profitability levels for the company are sitting at:
- -30.12 for the present operating margin
- +60.38 for the gross margin
The net margin for Veracyte Inc. stands at -29.71. The total capital return value is set at -10.31, while invested capital returns managed to touch -10.21. Equity return is now at value -11.10, with -9.90 for asset returns.
Based on Veracyte Inc. (VCYT), the company’s capital structure generated 2.92 points at debt to equity in total, while total debt to capital is 2.84. Total debt to assets is 2.69, with long-term debt to equity ratio resting at 2.55. Finally, the long-term debt to capital ratio is 2.47.
When we switch over and look at the enterprise to sales, we see a ratio of 19.31, with the company’s debt to enterprise value settled at 0.01. The receivables turnover for the company is 6.22 and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 22.39.